Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Vitamin A has been studied in the context of Acquired Immune Deficiency Syndrome (AIDS), particularly due to its role in immune function, mucosal integrity, and the modulation of inflammatory responses. Scientific evidence, especially from studies in low-resource settings, indicates that vitamin A deficiency is common among individuals with HIV/AIDS and is associated with worse clinical outcomes. Several randomized controlled trials have explored the effects of vitamin A supplementation in people with HIV/AIDS, especially in pregnant women and children. Some studies have shown that supplementation can reduce morbidity and mortality, improve immune function, and decrease the incidence of opportunistic infections, particularly in vitamin A-deficient populations. However, findings are mixed, and in some adult studies, high-dose supplementation did not show a significant effect on HIV progression or mortality. Notably, the World Health Organization recommends vitamin A supplementation for children with HIV in areas where vitamin A deficiency is a public health problem, and it is also used to reduce the severity of measles in HIV-infected children. In adults, routine supplementation is not universally recommended unless there is evidence of deficiency. Overall, while there is scientific rationale and some clinical evidence supporting the use of vitamin A in certain HIV/AIDS populations, especially where deficiency is common, the strength of the evidence is moderate and not uniformly conclusive across all groups.

More about Vitamin A (unspecified)
More about Acquired Immune Deficiency Syndrome

Other ingredients used for Acquired Immune Deficiency Syndrome

Other health conditions supported by Vitamin A (unspecified)

Products containing Vitamin A (unspecified)